Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
VISTA GOLD CORPVista Gold Corp. Reports Q3 2025 Financial Results with Consolidated Net Loss of $723,000
Virginia National Bankshares CorpVirginia National Bankshares Reports Q3 2025 Financial Results with $4.6 Million Net Income
Pulmonx CorpPulmonx Corporation Reports 5.5% Revenue Growth to $21.5 Million in Q3 2025
GULF ISLAND FABRICATION INCGulf Island Fabrication Reports Revenue Increase to $51.5 Million in Q3 2025
STRATUS PROPERTIES INCStratus Properties Reports 44% Revenue Decline and Increased Net Loss in Q3 2025
Presidio Property Trust, Inc.Presidio Property Trust Reports Revenue Decline and Improved Net Loss in Q3 2025
IRIDEX CORPIRIDEX Corporation Reports 7.8% Revenue Growth in Q3 2025
Churchill Capital Corp X/CaymanChurchill Capital Corp X Reports Financial Developments and Merger Agreement with ColdQuanta
NOMAD POWER SOLUTIONS, INC.Lixte Biotechnology Reports $3.47 Million Net Loss in Q3 2025, Cash Reserves Increase to $2.89 Million
micromobility.com Inc.Micromobility.com Reports Q3 2025 Revenue Growth Amid Strategic Shift to IT Services
U S GLOBAL INVESTORS INCU.S. Global Investors Reports $1.5 Million Net Income for Q3 2025
BEST SPAC I Acquisition Corp.BEST SPAC I Acquisition Corp. Reports Financial Results and Merger Agreement with HDEducation Group
Willow Lane Acquisition Corp.Willow Lane Acquisition Corp. Reports Q3 2025 Net Income of $785,531 and Enters Business Combination Agreement
Kezar Life Sciences, Inc.Kezar Life Sciences Reports Improved Net Loss of $11.2 Million in Q3 2025
Viskase Holdings, Inc.Enzon Pharmaceuticals Reports Decline in Revenue and Increased Losses in Q3 2025
Autolus Therapeutics plcAutolus Therapeutics Reports $21.1M Revenue from AUCATZYL Launch in Q3 2025
Lyell Immunopharma, Inc.Lyell Immunopharma Reports $38.8 Million Net Loss in Q3 2025, Revenue Declines
AN2 Therapeutics, Inc.AN2 Therapeutics Reports Q3 2025 Financial Results with Reduced Net Loss
RMR GROUP INC.RMR Group Inc. Reports $182.7 Million Revenue, 5.8% Decline for Fiscal Year Ending September 30, 2025
Semler Scientific, Inc.Semler Scientific Reports 45% Revenue Decline in Q3 2025, Despite Increased Net Income Driven by Bitcoin Gains
QUICKLOGIC CorpQuickLogic Reports 52% Revenue Decline and Increased Net Loss in Q3 2025
Immuneering CorpImmuneering Reports Q3 2025 Financial Results with Increased Net Loss and Significant Cash Reserves
Nuwellis, Inc.Nuwellis Reports Q3 2025 Financial Results with $2.2M in Net Sales and Increased Net Loss
Acumen Pharmaceuticals, Inc.Acumen Pharmaceuticals Reports $26.5M Net Loss in Q3 2025, Sees Increase in R&D Expenses
Avidbank Holdings, Inc.Avidbank Holdings Reports $37.7 Million Net Loss in Q3 2025, Despite Increased Net Interest Income